Corte Madera, CA, United States of America

Victoria Sluzky

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2009-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria Sluzky. Retrieved from https://idiyas.com/inventor/victoria-sluzky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Victoria Sluzky: Innovator in Pharmaceutical Formulations

Introduction

Victoria Sluzky is a prominent inventor based in Corte Madera, CA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable tablet formulations. With a total of 2 patents to her name, her work has the potential to impact treatment methods significantly.

Latest Patents

Victoria's latest patents focus on stable solid formulations of tetrahydrobiopterin. These inventions include processes for producing these formulations and treatment methods utilizing them. Her innovative approach addresses the challenges associated with stability in pharmaceutical products.

Career Highlights

Victoria Sluzky is currently employed at BioMarin Pharmaceutical Inc., where she continues to advance her research and development efforts. Her expertise in pharmaceutical formulations has positioned her as a valuable asset in the industry.

Collaborations

Some of her notable coworkers include Steven Jungles and Mark Henderson. Their collaborative efforts contribute to the innovative environment at BioMarin Pharmaceutical Inc.

Conclusion

Victoria Sluzky's work in stable tablet formulations exemplifies her commitment to advancing pharmaceutical science. Her contributions are paving the way for improved treatment options in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…